Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Make your likes visible on Facebook?

Connect your Facebook account to Prezi and let your likes appear on your timeline.
You can change this under Settings & Account at any time.

No, thanks

DIABETES & HYPERTENSION

No description
by

Qasim Khan

on 31 July 2015

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of DIABETES & HYPERTENSION

DIABETES & HYPERTENSION
PARTNERS IN CRIME

The Two Terrorists
Management Guidelines
Summary
Epidemiology
MANAGEMENT GUIDLINES
THANK YOU
Dr. Tariq Waseem
Professor of Medicine

King Edward Medical University, Mayo Hospital, Lahore






Pakistan is 7th largest country in terms of Diabetes population and it will be 4th largest by the year 2030.
WHO 2011: 12.9 million people with diabetes (8% of total population) Diagnosed : 9.4 million, Undiagnosed: 3.5 million Pre diabetes: 38 million people 20.5% women and 15.9% men have prediabetes .
NHSP: Hypertension affects 18 percent of adults over 15 years of age and 33 percent of adults above 45. Only 50 percent of those affected are diagnosed. out of the 50 percent people diagnosed only half are treated.


What Causes HTN in DM
Metabolic Syndrome- Mainly IR, BG, Obesity, ED
Excessive RAAS Acivity
HTN d/t Nephropathy in T2DM-GS-KWS
Renal Scarring : Recurrent Pyelonephritis
Endocrine : Cushing's, Conn's, Pheochromocytoma, Acromegaly
Coincidental: DM on existing Hypertension
Diabetogenic Antihypertensive drugs (D&B)
Drugs causing both HTN Dm : OCP, CS

Difficulties of HTN in DM
Relative Risk of DM + HTN
Systolic HTN more common in DM
S-HTN is a stronger predictor of CVE
65% of T2DM have S-HTN
S-HTN is more difficult to control
Depression is more in DM – Adherence Rx
‘Clinician Inertia’ is a big problem
Glycemic control is the Only focus.

Evidence: Morbity & Mortality DM + HTN
NEW GUIDELINES In Management Of Hypertension

Anti-Hypertensive Drugs
Diabetes + HTN versus Diabetes
• Neuropathy 1.6
• Nephropathy 2.0
• Retinopathy 2.0
• Stroke 4.0
• CHD 3.0
• Mortality 2.0

OVERVIEW
EPIDEMIOLOGY
DM + HTN COMPLICATIONS
CLINICAL TRIALS EVIDENCE
MANAGEMENT GUIDELINES
ANTI-HYPERTENSIVE DRUGS
SUMMARY
DM+HTN COMPLICATIONS
Full transcript